XEOMIN

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug XEOMIN contains one active pharmaceutical ingredient (API):

1 Botulinum toxin type A UNII E211KPY694 - BOTULINUM TOXIN TYPE A

Botulinum toxin type A is a protein complex derived from Clostridium botulinum. The protein consists of type A neurotoxin and several other proteins. Under physiological conditions it is presumed that the complex dissociates and releases the pure neurotoxin. Intramuscular injection of the neurotoxin complex blocks cholinergic transport at the neuromuscular junction by preventing the release of acetylcholine. The nerve endings of the neuromuscular junction no longer respond to nerve impulses and secretion of the chemotransmitter is prevented (chemical denervation). Read about Botulinum toxin type A

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XEOMIN Powder for solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M03AX01	Botulinum toxin	M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AX Other muscle relaxants, peripherally acting agents
Discover more medicines within M03AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10994P, 11005F, 12087E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 587620050000117
Country: CA	Health Products and Food Branch	Identifier(s): 02324032, 02371081, 02383489
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 104-MBE-0617, 122-MBE-0218
Country: EE	Ravimiamet	Identifier(s): 1620267, 1620278, 1620289, 1620290, 1620302, 1620313, 1620324, 1620335, 1620346, 1654589, 1654590, 1654602, 1654613, 1654624
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 69292, 74067, 80801
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 093306, 120109, 552192
Country: FR	Base de données publique des médicaments	Identifier(s): 67411667, 67540690, 69086891
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 134524, 194314, 333432
Country: HK	Department of Health Drug Office	Identifier(s): 63224, 63225
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-480570177, HR-H-601583942, HR-H-708914098
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8427, 8428
Country: JP	医薬品医療機器総合機構	Identifier(s): 1229407E1029, 1229407E2025, 1229407E3021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1070625, 1070626, 1072736, 1072737, 1072738, 1072739, 1072740, 1072741, 1072742, 1073737, 1080251, 1080252, 1080253, 1080254
Country: MT	Medicines Authority	Identifier(s): MA025/00701, MA025/00702, MA025/00703
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 115967, 115975, 134759
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16626, 16643
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100192798, 100252030, 100368814
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60612001, W60612002, W60612003, W60612004, W60612005, W60612006, W60612007, W60612008, W60612009, W60613001, W60613002, W60613003, W60613004, W60613005, W60613006, W60613007, W62943001, W62943002, W62943003, W62943004, W62943005, W62943006, W62943007, W62943008, W62943009
Country: SG	Health Sciences Authority	Identifier(s): 14585P, 14586P
Country: US	FDA, National Drug Code	Identifier(s): 0259-1605, 0259-1610, 0259-1620, 0259-4110, 0259-4150, 46783-160, 46783-161, 46783-165
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/30.5/0223, 53/30.5/0224